The Texas Tech University Health Sciences Center is a public medical school based in Lubbock, Texas, with additional campuses in Abilene, Amarillo, Dallas, El Paso and the Permian Basin. TTUHSC serves more than 100 counties in the western portion of Texas.

During the past decade, Texas Tech University Health Sciences Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 43 clinical trials were completed, i.e. on average, 74.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 27 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Tech University Health Sciences Center" #1 sponsor was "SWOG Cancer Research Network" with 43 trials, followed by "Texas Tech University Health Sciences Center" with 40 trials sponsored, "National Cancer Institute (NCI)" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "Eastern Cooperative Oncology Group" with 6 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Tech University Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Texas Tech University Health Sciences Center" are "Lymphoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Breast Cancer" (7 trials), "Lung Cancer" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Texas Tech University Health Sciences Center" in a lesser frequency.

Most popular intervention types in "Texas Tech University Health Sciences Center" are "Drug" (103 trials), "Other" (36 trials), "Biological" (26 trials), "Procedure" (22 trials) and "Device" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "cyclophosphamide" (11 trials), "radiation therapy" (11 trials), "Placebo" (9 trials) and "cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Texas Tech University Health Sciences Center" are 125 trials for "All" genders, 34 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Tech University Health Sciences Center". undefined are not yet recruiting, 13 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Texas Tech University Health Sciences Center, undefined suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Tech University Health Sciences Center, 9 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 31 trials that are defined as “Not Applicable".

Texas Tech University Health Sciences Center has several departments that took part in Clinical trials: "Texas Tech University Health Sciences-Internal Medicine" - 4 trials, "Texas Tech Medical Center Department of Anesthesiology" - 2 trials, "Texas Tech University Health Sciences Center, Dept. of Neuropsychiatry" - 2 trials, "TTUHSC Orthopaedic Surgery MS 9436" - 2 trials